SCHEMBL499116

SCHEMBL499116

COc1cc(CC(=O)O)cc(OC)c1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.61
ALDH1A1 P00352 3/20 0.61
TSHR P16473 2/20 0.61
NFKB1 P19838 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
PTGS2 P35354 1/20 0.55
KMT2A Q03164 3/20 0.53
MEN1 O00255 1/20 0.53
CA5A P35218 1/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
POLB P06746 1/20 0.51
HTR2C P28335 2/20 0.50
HTR2A P28223 1/20 0.50
HTR2B P41595 1/20 0.50
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HTR1A P08908 1/20 0.49
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4002124 0.98 GAA (0.59) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL11157934 0.89 GAA (0.54) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL8080316 0.89 GAA (0.63) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL6195246 0.87 GAA (0.49) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL19532894 0.87 GAA (0.56) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL7046945 0.86 PTGS2 (0.57) GAAALDH1A1PTGS2KMT2AMEN1
SCHEMBL8930355 0.85 CA5A (0.55) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL9341764 0.85 KMT2A (0.54) GAAALDH1A1PTGS2KMT2AMEN1
SCHEMBL1572690 0.84 GAA (0.47) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL4965033 0.84 PTGS2 (0.55) GAAALDH1A1PTGS2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 618 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250162980-A1 METHODS FOR PREPARING MESCALINE JOURNEY COLAB CORP. 2025-05-22 US claimed
CN-115108905-B Method for producing (Z) -trifluoromethaneenol ester by copper-catalyzed regioselective olefination and trifluoromethylation of carboxylic acid 湖南大学 2025-04-08 CN claimed
CN-119431241-A Synthesis process of 5-methoxy laudan wine stone 上海升德医药科技有限公司 2025-02-14 CN claimed
CN-118771963-A Method for realizing double-carbon functional conversion of olefin through carboxylic acid decarboxylation by using sulfur hexafluoride as oxidizing agent 国网安徽省电力有限公司电力科学研究院 2024-10-15 CN claimed
CN-118771956-A Carboxylic acid decarboxylation coupling conversion method using sulfur hexafluoride as oxidizing reagent 国网安徽省电力有限公司电力科学研究院 2024-10-15 CN claimed
CN-118067891-A Method for detecting impurities in 3,4, 5-trimethoxyphenylacetic acid 四川科瑞德制药股份有限公司 2024-05-24 CN claimed
CN-116836081-A Ether epoxy toughening agent and preparation method and application thereof 中国林业科学研究院林产化学工业研究所 2023-10-03 CN claimed
WO-2023164178-A2 METHODS FOR PREPARING MESCALINE JOURNEY COLAB CORP. (US) 2023-08-31 WO claimed
CN-114907262-B Method for synthesizing 5' -methoxy laudan 广东嘉博制药有限公司 2023-06-16 CN claimed
CN-114057642-B Synthetic method of mickey ammonium chloride intermediate 广东嘉博制药有限公司 2023-03-28 CN claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
EP-1430016-A4 3,4,5-TRIMETHOXY PHENYL-BASED ESTER COMPOUND AND PREPARATION METHOD THEREOF AND WHITENING COSMETIC COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORP (KR) 2006-01-11 EP claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
EP-1430016-A1 3,4,5-TRIMETHOXY PHENYL-BASED ESTER COMPOUND AND PREPARATION METHOD THEREOF AND WHITENING COSMETIC COMPOSITION CONTAINING THE SAME Amorepacific Corporation (KR) 2004-06-23 EP claimed
WO-2003027055-A1 3,4,5-TRIMETHOXY PHENYL-BASED ESTER COMPOUND AND PREPARATION METHOD THEREOF AND WHITENING COSMETIC COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2003-04-03 WO claimed
US-6398857-B1 ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS XEROX CORPORATION 2002-06-04 US claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 GAA 1358/4885ALDH1A1 1569/4885TSHR 2894/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 GAA 958/4885ALDH1A1 1723/4885TSHR 4082/4885
US-20250162980-A1 METHODS FOR PREPARING MESCALINE IL4I1, ME3, LIG3 GAA 2504/4885ALDH1A1 216/4885TSHR 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.